Patents Assigned to Sen Capital, LLC.
  • Anti-diabetic compounds
    Patent number: 8741882
    Abstract: The preset invention relates to a new oral anti-diabetic compound prepared by synthesizing a steroid and a guanide or biguanide, which is eliminated via the hepatic route, instead of the renal route, to avoid adverse effects of administering metformin in diabetic patients with renal dysfunction. A pharmaceutical composition comprising the compound of the invention and the method for treating diabetes using the compound are also provided.
    Type: Grant
    Filed: January 20, 2012
    Date of Patent: June 3, 2014
    Assignee: Sen Capital, LLC.
    Inventor: John Soong